what to expect, page-28

There has been a fair degree if caution as Oct 1 results approach. There is now a likelihood the share price won't spike prior to the results as much as was hoped. This is most likely because there is trepidation about the results being unspectacular or worse, a failure. Judging by the comments on this forum there are many holders who are questioning whether the depressed price is a prelude to poor results. I'm not sure the news needs to be utterly spectacular but rather, it needs to simply confirm the product works and there is a genuine need for CVac.

Such confirmation makes an investment in Prima a much safer holding, with the prospect of commercialisation not guaranteed, but at least far more foreseeable. With a proven product, investors can breathe easier and have reason to believe in a viable future with the prospect of a large pharmaceutical company funding production via joint venture.

At this moment in time we can only hope CVac works effectively, a relief rally could very well follow any positive news confirming such. Just my thoughts as l prepare to leave for work to make money the hard way.